Geneos Wealth Management’s Flaherty & Crumrine Total Return Fund FLC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21K | Buy |
1,265
+250
| +25% | +$4.37K | ﹤0.01% | 1745 |
|
|
2025
Q4 | $17.8K | Hold |
1,015
| – | – | ﹤0.01% | 1774 |
|
|
2025
Q3 | $18.1K | Hold |
1,015
| – | – | ﹤0.01% | 1757 |
|
|
2025
Q2 | $17.3K | Sell |
1,015
-1,015
| -50% | -$16.7K | ﹤0.01% | 2099 |
|
|
2025
Q1 | $34.1K | Buy |
2,030
+687
| +51% | +$11.6K | ﹤0.01% | 2103 |
|
|
2024
Q4 | $22.4K | Buy |
1,343
+328
| +32% | +$5.54K | ﹤0.01% | 1676 |
|
|
2024
Q3 | $17.5K | Hold |
1,015
| – | – | ﹤0.01% | 1605 |
|
|
2024
Q2 | $15.8K | Sell |
1,015
-120
| -11% | -$1.82K | ﹤0.01% | 1412 |
|
|
2024
Q1 | $17.5K | Sell |
1,135
-480
| -30% | -$7.22K | ﹤0.01% | 1397 |
|
|
2023
Q4 | $23.5K | Hold |
1,615
| – | – | ﹤0.01% | 1300 |
|
|
2023
Q3 | $22.1K | Hold |
1,615
| – | – | ﹤0.01% | 1347 |
|
|
2023
Q2 | $23.2K | Hold |
1,615
| – | – | ﹤0.01% | 1322 |
|
|
2023
Q1 | $23.7K | Hold |
1,615
| – | – | ﹤0.01% | 1286 |
|
|
2022
Q4 | $25.5K | Sell |
1,615
-1,574
| -49% | -$24.6K | ﹤0.01% | 1259 |
|
|
2022
Q3 | $49K | Sell |
3,189
-19,073
| -86% | -$338K | ﹤0.01% | 1035 |
|
|
2022
Q2 | $398K | Sell |
22,262
-875
| -4% | -$16.4K | 0.02% | 560 |
|
|
2022
Q1 | $461K | Sell |
23,137
-2,762
| -11% | -$57.6K | 0.02% | 544 |
|
|
2021
Q4 | $590K | Sell |
25,899
-3,493
| -12% | -$81.9K | 0.02% | 521 |
|
|
2021
Q3 | $703K | Sell |
29,392
-2,142
| -7% | -$51.5K | 0.03% | 484 |
|
|
2021
Q2 | $764K | Sell |
31,534
-393
| -1% | -$9.55K | 0.03% | 446 |
|
|
2021
Q1 | $789K | Hold |
31,927
| – | – | 0.02% | 500 |
|
|
2020
Q4 | $762K | Sell |
31,927
-70
| -0.2% | -$1.58K | 0.03% | 429 |
|
|
2020
Q3 | $678K | Hold |
31,997
| – | – | 0.04% | 366 |
|
|
2020
Q2 | $633K | Buy |
31,997
+435
| +1% | +$8.31K | 0.04% | 367 |
|
|
2020
Q1 | $526K | Sell |
31,562
-420
| -1% | -$8.85K | 0.04% | 369 |
|
|
2019
Q4 | $712K | Sell |
31,982
-211
| -0.7% | -$4.76K | 0.04% | 364 |
|
|
2019
Q3 | $717K | Sell |
32,193
-544
| -2% | -$11.6K | 0.04% | 335 |
|
|
2019
Q2 | $663K | Sell |
32,737
-1,370
| -4% | -$27K | 0.04% | 350 |
|
|
2019
Q1 | $655K | Buy |
34,107
+3
| +0% | +$56 | 0.04% | 342 |
|
|
2018
Q4 | $577K | Sell |
34,104
-39
| -0.1% | -$684 | 0.04% | 346 |
|
|
2018
Q3 | $635K | Buy |
34,143
+2,453
| +8% | +$47.8K | 0.04% | 335 |
|
|
2018
Q2 | $618K | Sell |
31,690
-2,134
| -6% | -$41.4K | 0.05% | 289 |
|
|
2018
Q1 | $670K | Sell |
33,824
-2,334
| -6% | -$47.3K | 0.06% | 263 |
|
|
2017
Q4 | $781K | Buy |
36,158
+1,760
| +5% | +$37.7K | 0.07% | 248 |
|
|
2017
Q3 | $738K | Sell |
34,398
-2,149
| -6% | -$46.5K | 0.07% | 238 |
|
|
2017
Q2 | $814K | Sell |
36,547
-1,074
| -3% | -$23.4K | 0.08% | 220 |
|
|
2017
Q1 | $796K | Sell |
37,621
-20,148
| -35% | -$413K | 0.08% | 207 |
|
|
2016
Q4 | $1.15M | Sell |
57,769
-8,001
| -12% | -$162K | 0.15% | 143 |
|
|
2016
Q3 | $1.38M | Buy |
65,770
+819
| +1% | +$17.9K | 0.19% | 128 |
|
|
2016
Q2 | $1.42M | Buy |
64,951
+27,094
| +72% | +$570K | 0.21% | 115 |
|
|
2016
Q1 | $768K | Buy |
+37,857
| New | +$749K | 0.12% | 175 |
|
Other funds holding FLC
SIA
AAM
NWMP
SFS
HWAM
SAM
GC
Geneos Wealth Management's FLC Position: Q1 2026 in Review
Geneos Wealth Management increased its Flaherty & Crumrine Total Return Fund (FLC) stake by 25% in Q1 2026, buying an estimated $4.37K and bringing the position to 1,265 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.
Geneos Wealth Management first reported a position in FLC in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.42M in Q2 2016. 50 funds tracked by Wall St. Rank hold FLC as of Q1 2026.
- Geneos Wealth Management held 1,265 shares of Flaherty & Crumrine Total Return Fund worth $21K as of Q1 2026.
- Geneos Wealth Management bought 250 Flaherty & Crumrine Total Return Fund shares in Q1 2026, an estimated $4.37K.
- Flaherty & Crumrine Total Return Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1745 holding.
- Geneos Wealth Management first reported a position in Flaherty & Crumrine Total Return Fund in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Flaherty & Crumrine Total Return Fund position peaked at $1.42M in Q2 2016.
- 50 funds tracked by Wall St. Rank held Flaherty & Crumrine Total Return Fund as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.